Pros and Cons in Using Population-Based Registers for Assessing the Fetal Safety of Drugs-Reply

Research output: Contribution to journalComment/debateResearchpeer-review

Standard

Pros and Cons in Using Population-Based Registers for Assessing the Fetal Safety of Drugs-Reply. / Andersson, Niklas Worm; Andersen, Jon Trærup.

In: JAMA Pediatrics, Vol. 175, No. 4, 04.2021, p. 427-428.

Research output: Contribution to journalComment/debateResearchpeer-review

Harvard

Andersson, NW & Andersen, JT 2021, 'Pros and Cons in Using Population-Based Registers for Assessing the Fetal Safety of Drugs-Reply', JAMA Pediatrics, vol. 175, no. 4, pp. 427-428. https://doi.org/10.1001/jamapediatrics.2020.5323

APA

Andersson, N. W., & Andersen, J. T. (2021). Pros and Cons in Using Population-Based Registers for Assessing the Fetal Safety of Drugs-Reply. JAMA Pediatrics, 175(4), 427-428. https://doi.org/10.1001/jamapediatrics.2020.5323

Vancouver

Andersson NW, Andersen JT. Pros and Cons in Using Population-Based Registers for Assessing the Fetal Safety of Drugs-Reply. JAMA Pediatrics. 2021 Apr;175(4):427-428. https://doi.org/10.1001/jamapediatrics.2020.5323

Author

Andersson, Niklas Worm ; Andersen, Jon Trærup. / Pros and Cons in Using Population-Based Registers for Assessing the Fetal Safety of Drugs-Reply. In: JAMA Pediatrics. 2021 ; Vol. 175, No. 4. pp. 427-428.

Bibtex

@article{1a58b9ff0aac4f268fcd34b0c83385ef,
title = "Pros and Cons in Using Population-Based Registers for Assessing the Fetal Safety of Drugs-Reply",
author = "Andersson, {Niklas Worm} and Andersen, {Jon Tr{\ae}rup}",
year = "2021",
month = apr,
doi = "10.1001/jamapediatrics.2020.5323",
language = "English",
volume = "175",
pages = "427--428",
journal = "JAMA Pediatrics",
issn = "2168-6203",
publisher = "The JAMA Network",
number = "4",

}

RIS

TY - JOUR

T1 - Pros and Cons in Using Population-Based Registers for Assessing the Fetal Safety of Drugs-Reply

AU - Andersson, Niklas Worm

AU - Andersen, Jon Trærup

PY - 2021/4

Y1 - 2021/4

U2 - 10.1001/jamapediatrics.2020.5323

DO - 10.1001/jamapediatrics.2020.5323

M3 - Comment/debate

C2 - 33464312

AN - SCOPUS:85099606328

VL - 175

SP - 427

EP - 428

JO - JAMA Pediatrics

JF - JAMA Pediatrics

SN - 2168-6203

IS - 4

ER -

ID: 284012238